HK1256033A1 - 用於刺激免疫系統的肽 - Google Patents

用於刺激免疫系統的肽

Info

Publication number
HK1256033A1
HK1256033A1 HK18115085.4A HK18115085A HK1256033A1 HK 1256033 A1 HK1256033 A1 HK 1256033A1 HK 18115085 A HK18115085 A HK 18115085A HK 1256033 A1 HK1256033 A1 HK 1256033A1
Authority
HK
Hong Kong
Prior art keywords
stimulate
peptides
immune system
immune
Prior art date
Application number
HK18115085.4A
Other languages
English (en)
Inventor
Blanche Tamarit
Jacques Theze
Original Assignee
Diaccurate
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diaccurate filed Critical Diaccurate
Publication of HK1256033A1 publication Critical patent/HK1256033A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
HK18115085.4A 2015-10-09 2018-11-26 用於刺激免疫系統的肽 HK1256033A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15306597 2015-10-09
PCT/EP2016/073960 WO2017060405A1 (en) 2015-10-09 2016-10-07 Use of peptides to stimulate the immune system

Publications (1)

Publication Number Publication Date
HK1256033A1 true HK1256033A1 (zh) 2019-09-13

Family

ID=54329484

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115085.4A HK1256033A1 (zh) 2015-10-09 2018-11-26 用於刺激免疫系統的肽

Country Status (7)

Country Link
US (1) US11154587B2 (zh)
EP (1) EP3359179A1 (zh)
JP (1) JP2018531945A (zh)
CN (1) CN108472329B (zh)
CA (1) CA3001174A1 (zh)
HK (1) HK1256033A1 (zh)
WO (1) WO2017060405A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018526440A (ja) 2015-08-31 2018-09-13 ディアキュレートＤｉａｃｃｕｒａｔｅ 免疫系を刺激するためのインドール化合物の使用
EP3530282A1 (en) 2018-02-27 2019-08-28 Diaccurate Therapeutic methods
EP3693063A1 (en) 2019-02-06 2020-08-12 Diaccurate Methods and compositions for treating cancer
EP3858357A1 (en) 2020-01-28 2021-08-04 Diaccurate Use of azole compounds to stimulate the immune system and as inhibitors for s-pla2gib
WO2021214039A1 (en) 2020-04-21 2021-10-28 Diaccurate Spla2hgib-binding molecules and uses thereof
WO2021239666A1 (en) 2020-05-26 2021-12-02 Diaccurate Therapeutic methods
US20230270817A1 (en) * 2020-07-22 2023-08-31 Filamon Pty Ltd Vimentin inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP182398A0 (en) * 1998-02-13 1998-03-12 Garvan Institute Of Medical Research Cyclic peptide inhibitors of pla2
AUPS282602A0 (en) * 2002-06-07 2002-06-27 Garvan Institute Of Medical Research Method of inhibiting cell proliferation
EP2960252A1 (en) 2014-06-26 2015-12-30 Institut Pasteur Phospholipase for treatment of immunosuppression
JP2018526440A (ja) 2015-08-31 2018-09-13 ディアキュレートＤｉａｃｃｕｒａｔｅ 免疫系を刺激するためのインドール化合物の使用
EP3530282A1 (en) 2018-02-27 2019-08-28 Diaccurate Therapeutic methods

Also Published As

Publication number Publication date
JP2018531945A (ja) 2018-11-01
CA3001174A1 (en) 2017-04-13
US20180296632A1 (en) 2018-10-18
CN108472329B (zh) 2022-04-05
CN108472329A (zh) 2018-08-31
EP3359179A1 (en) 2018-08-15
WO2017060405A1 (en) 2017-04-13
US11154587B2 (en) 2021-10-26

Similar Documents

Publication Publication Date Title
IL290496A (en) Therapeutic antibodies and their uses
IL252005B (en) Transfer of biological molecules to immune cells
IL252659A0 (en) Human antibodies to influenza hemagglutinin
IL248392A0 (en) Human antibodies to Middle East respiratory syndrome coronavirus spike protein
IL251822A0 (en) Variants of interferon alpha-2B
HK1256033A1 (zh) 用於刺激免疫系統的肽
EP3200811A4 (en) Use of annexin v as a method to block tumor induced immunosuppression of the innate immune response
IL285882A (en) Medicinal uses for l–4–chlorokynurenine
IL287985A (en) A peptide derived from koc1 and a component containing it
HK1256875A1 (zh) 加强對大腦的藥物輸送
IL250215B (en) A peptide derived from cdca1 and a component containing it
IL250235A0 (en) A peptide derived from urlc10 and a component containing it
HK1251873A1 (zh) 治療性肽
GB201504211D0 (en) Use of peptides
AP2015008263A0 (en) Analysis of human immune status